Aβ42, Presenilins, and Alzheimer’s Disease
- 28 February 1998
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 19 (1) , S11-S13
- https://doi.org/10.1016/s0197-4580(98)00027-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cellsNature Medicine, 1997
- The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta 42(43)Neurology, 1997
- Amyloid (Aβ) deposition in chromosome 1–linked Alzheimer's disease: The volga german familiesAnnals of Neurology, 1997
- Familial Alzheimer's disease-linked mutations at Val717 of amyloid precursor protein are specific for the increased secretion of A beta 42(43).Biochemical and Biophysical Research Communications, 1996
- Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ42(43)Annals of Neurology, 1996
- Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's diseaseNature Medicine, 1996
- Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down SyndromeAnnals of Neurology, 1995
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp 717 ) MutantsScience, 1994
- The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's diseaseBiochemistry, 1993